Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

?dT Cell Cancer Immunotherapy : Evidence-Based Perspectives for Clinical Translation, Hardback Book

?dT Cell Cancer Immunotherapy : Evidence-Based Perspectives for Clinical Translation Hardback

Edited by Marta (University College London, Experimental Paediatric Oncology Research Group and Alloge Barisa

Part of the Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy series



?d T Cell Cancer Immunotherapy: Evidence-Based Perspectives for Clinical Translation discusses the current pre-clinical and clinical ?d T cell landscape.

The book not only focuses on the promises of what’s to come, but also on the challenges faced by the field.

Particular attention is given to summarizing recent advances on what is known about relevant areas of ?d T cell biology on summarizing the ‘big picture’ clinical situation, an up-to-date systematic clinical trial review covering autologous, allogeneic, engineered and non-engineered therapies, and perspectives on the types of cutting-edge gene-engineering that may be required to enhance the effect-size and durability of therapeutic efficacy.

Content provides updated and comprehensive insights into the current state of ?d T cell immunotherapy, including discussions on the promise as well as challenges of the field that is of interest to existing translational ?d T cell specialists, the proliferating range of academic scientists and commercial scientists entering the field, as well as clinicians who may encounter ?d T cell immunotherapy in the clinic or are wishing to familiarize themselves with non-canonical lymphocyte immunotherapy.



Free Home Delivery

on all orders

Pick up orders

from local bookshops